XML 59 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Geographic and Product Data
 6 Months Ended
Jun. 29, 2012
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]

Note 10 — Geographic and Product Data

 

The Company markets and sells its products in approximately 60 countries and has manufacturing sites in the United States, Switzerland and Japan. Other than the United States, Japan, Korea, and China, the Company does not conduct business in any country in which its sales exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):

 

    Three Months Ended     Six Months Ended  
    June 29,     July 1,     June 29,     July 1,  
    2012     2011     2012     2011  
United States   $ 3,216     $ 3,705     $ 6,390     $ 7,238  
Japan     4,094       3,890       7,951       7,734  
Korea     1,721       2,009       3,624       3,394  
China     2,141       1,803       4,247       3,007  
Other     4,770       4,862       9,239       9,745  
Total   $ 15,942     $ 16,269     $ 31,451     $ 31,118  

 

100% of the Company’s sales are generated from the ophthalmic surgical product segment and therefore the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are implantable Collamer lenses (“ICLs”) used in refractive surgery and intraocular lenses (“IOLs”) used in cataract surgery. The composition of the Company’s net sales by product line is as follows (in thousands):

 

    Three Months Ended     Six Months Ended  
    June 29,     July 1,     June 29,     July 1,  
    2012     2011     2012     2011  
ICLs   $ 8,606     $ 8,293     $ 17,211     $ 15,191  
IOLs     6,774       7,076       13,132       14,205  
Core products     15,380       15,369       30,343       29,396  
Other Surgical Products     562       900       1,108       1,722  
Total   $ 15,942     $ 16,269     $ 31,451     $ 31,118  

 

The Company sells its products internationally, which subjects the Company to several potential risks, including fluctuating foreign currency exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.